Oppenheimer lowered the firm’s price target on Integral Ad Science to $20 from $25 on weaker first half of the year outlook due to volume discounts for certain large clients in exchange for longer duration contracts and higher minimum spend levels. While investors worried about a more competitive pricing environment, the firm believes switching costs remain high between vendors. Oppenheimer keeps an Outperform rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IAS:
- IAS Reports Fourth Quarter and Full Year 2023 Financial Results
- Integral Ad expands AI-driven safety and suitability measurement to Meta
- Integral Ad Science initiated with a Buy at BofA, sees long runway for growth
- Integral Ad Science initiated with a Buy at BofA
- ‘2024 Will Be a Breakout Year for AdTech,’ According to BMO — Here Are 3 Stocks to Take Advantage